(Q54966717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2 references

29 May 2020

31 October 2020

0 references

0 references

Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

6 references

7 August 2019

13 December 2019

15 December 2019

21 December 2019

29 May 2020

31 October 2020

1 reference

7 August 2019

1 reference

1 reference

13 December 2019

1 reference

15 December 2019

1 reference

21 December 2019

1 reference

31 October 2020

1 reference

non-invasive diagnostics

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Fan Dong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yifan Shen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Tianyuan Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Xianjin Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Fengbin Gao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Shan Zhong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Shanwen Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

21 March 2018

10 references

3 April 2019

22 April 2019

19 June 2019

7 August 2019

13 December 2019

15 December 2019

21 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

29 May 2020

31 October 2020

World Journal of Surgical Oncology

8 references

19 June 2019

7 August 2019

13 December 2019

15 December 2019

21 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

29 May 2020

31 October 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

21 March 2020

copyright license

9 references

3 April 2019

22 April 2019

19 June 2019

7 August 2019

13 December 2019

15 December 2019

21 December 2019

29 May 2020

on focus list of Wikimedia project

31 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s12957-018-1358-x

0 references

cites work

Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

16 June 2018

Cancer Statistics, 2017.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Diagnostic Performance of Fas Ligand mRNA Expression for Acute Rejection after Kidney Transplantation: A Systematic Review and Meta-Analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Fibronectin Mechanobiology Regulates Tumorigenesis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

New strategies in muscle-invasive bladder cancer: on the road to personalized medicine

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Urinary markers in bladder cancer

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Meta-DiSc: a software for meta-analysis of test accuracy data.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Quantifying heterogeneity in a meta-analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Current concepts in biomarker technology for bladder cancers

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Measuring the accuracy of diagnostic systems

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s).

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

The clinical relevance of urine-based markers for diagnosis of bladder cancer.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Conservative management of low risk superficial bladder tumors.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Diagnosis of bladder cancer by analysis of urinary fibronectin

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5863379

Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies

13 August 2018

1 reference

12 December 2020

Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin

1 reference

12 December 2020

Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens

1 reference

12 December 2020

Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer

1 reference

12 December 2020

Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer

1 reference

12 December 2020

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

12 December 2020

Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark

1 reference

12 December 2020

Urine markers for bladder cancer surveillance: a systematic review

1 reference

12 December 2020

Urine cytology discrepancies: frequency, causes, and outcomes

1 reference

12 December 2020

10.1186/S12957-018-1358-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 March 2020

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s12957-018-1358-x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29562940%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

29562940

1 reference